clonidine has been researched along with Rosacea in 6 studies
Clonidine: An imidazoline sympatholytic agent that stimulates ALPHA-2 ADRENERGIC RECEPTORS and central IMIDAZOLINE RECEPTORS. It is commonly used in the management of HYPERTENSION.
clonidine (amino form) : A clonidine that is 4,5-dihydro-1H-imidazol-2-amine in which one of the amino hydrogens is replaced by a 2,6-dichlorophenyl group.
Rosacea: A cutaneous disorder primarily of convexities of the central part of the FACE, such as FOREHEAD; CHEEK; NOSE; and CHIN. It is characterized by FLUSHING; ERYTHEMA; EDEMA; RHINOPHYMA; papules; and ocular symptoms. It may occur at any age but typically after age 30. There are various subtypes of rosacea: erythematotelangiectatic, papulopustular, phymatous, and ocular (National Rosacea Society's Expert Committee on the Classification and Staging of Rosacea, J Am Acad Dermatol 2002; 46:584-7).
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effects of clonidine hydrochloride, an agent effective in suppressing other types of flushing reactions, were investigated in patients with erythematotelangiectatic rosacea." | 9.05 | Effect of subdepressor clonidine on flushing reactions in rosacea. Change in malar thermal circulation index during provoked flushing reactions. ( Wilkin, JK, 1983) |
| "The effects of clonidine hydrochloride, an agent effective in suppressing other types of flushing reactions, were investigated in patients with erythematotelangiectatic rosacea." | 5.05 | Effect of subdepressor clonidine on flushing reactions in rosacea. Change in malar thermal circulation index during provoked flushing reactions. ( Wilkin, JK, 1983) |
| "Flushing in rosacea has been investigated by means of (a) pharmacological inhibition of some possible chemical mediators and (b) titration of bradykinin as a possible effector directly in the blood." | 3.66 | Flushing in rosacea: a possible mechanism. ( Cipriani, C; Divano, C; Guarrera, M; Parodi, A; Rebora, A, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (66.67) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Wilkin, JK | 1 |
| Guarrera, M | 1 |
| Parodi, A | 1 |
| Cipriani, C | 1 |
| Divano, C | 1 |
| Rebora, A | 1 |
| Van Landuyt, H | 1 |
| Joubert-Lequain, I | 1 |
| Humbert, P | 1 |
| Lucas, A | 1 |
| Drobacheff, C | 1 |
| Mercier, M | 1 |
| Laurent, R | 1 |
| Cunliffe, WJ | 1 |
| Dodman, B | 1 |
| Binner, JG | 1 |
| Grosshans, E | 1 |
4 trials available for clonidine and Rosacea
| Article | Year |
|---|---|
Effect of subdepressor clonidine on flushing reactions in rosacea. Change in malar thermal circulation index during provoked flushing reactions.
Topics: Clonidine; Face; Female; Humans; Male; Rosacea; Skin Temperature | 1983 |
[Treatment of rosacea. Clonidine (0.075 mg per day) versus placebo (initial results)].
Topics: Adrenergic alpha-Agonists; Clonidine; Humans; Placebos; Rosacea | 1997 |
Clonidine and facial flushing in rosacea.
Topics: Clinical Trials as Topic; Clonidine; Drug Evaluation; Erythema; Face; Humans; Rosacea | 1977 |
[Rosacea].
Topics: Body Temperature; Clinical Trials as Topic; Clonidine; Female; Humans; Isotretinoin; Male; Metronida | 1988 |
2 other studies available for clonidine and Rosacea
| Article | Year |
|---|---|
INN Common stem: -onidine.
Topics: Adrenergic alpha-2 Receptor Agonists; Antimalarials; Brimonidine Tartrate; Cinchona Alkaloids; Cloni | 2017 |
Flushing in rosacea: a possible mechanism.
Topics: Adult; Aspirin; Body Temperature; Bradykinin; Clonidine; Epinephrine; Face; Female; Humans; Indometh | 1982 |